Tradestie Institutional Equity Comparison Engine
AXNX vs ATRC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ATRC Overall Edge
ATRC Captures Institutional Edge (4โ0 Pillars ยท 9โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AtriCure, Inc. (ATRC) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ATRC at 122.1x Forward P/E and 2.9% operating margin (+15.0% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ATRC sits in UNCLASSIFIED (74th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ATRC
AXNX N/M vs ATRC 122.1x Fwd P/E
Growth & Margin Winner
ATRC
Op Margin N/A vs 2.9% ยท YoY N/A vs +15.0%
Momentum & Technical Winner
ATRC
1Y +16.9% vs +62.0% ยท 52W Pos 50% vs 74%
Options & Structure Winner
ATRC
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (74th %ile IV)
AXNX
US Equity
AXNX
Institutional Equity
$0.83
-8.28% 1D
Market Cap
N/A
1M Return
-26.54%
1Y Return
+16.92%
Forward P/E
N/M
Unified AI Score
52.1 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
ATRC
NASDAQ
AtriCure, Inc.
Surgical & Medical Instruments & Apparatus
$55.39
+2.37% 1D
Market Cap
$2.8B
1M Return
-6.59%
1Y Return
+62.05%
Forward P/E
122.1x
Unified AI Score
53.7 / 100
HOLD
Tech 42.0
Fund 47.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AXNX +16.92%
ATRC +62.05%
Spread: +19.52 pp (AXNX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AXNX TTM Op. Margin: N/A
ATRC TTM Op. Margin: 2.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AXNX vs ATRC. Trailing 12-month operating profitability (AXNX N/A vs ATRC 2.9%) and valuation multiples (AXNX N/M vs ATRC 122.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AXNX | ATRC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $2.8B | Larger Scale | ATRC |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | 122.1x | Lower Multiple | ATRC |
| Revenue Growth (YoY) Growth | N/A | +15.0% | Higher Growth | ATRC |
| Operating Margin (TTM) Profitability | N/A | 2.9% | Higher Margin | ATRC |
| Net Profit Margin Profitability | N/A | 2.5% | Higher Margin | ATRC |
| Return on Equity (ROE) Capital Efficiency | N/A | 2.9% | Higher ROE | ATRC |
| 52-Week Range Position Momentum | 50% ($0โ$1) | 74% ($25โ$66) | Stronger Trend | ATRC |
| Beta / 30D Volatility Risk Regime | N/A | 0.47ฮฒ ยท 49% Vol | Lower Realized Risk | ATRC |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 53.7 / 100 (HOLD) | Higher Composite | ATRC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AXNX vs ATRC Buy Guide
AXNX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ATRC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
74th %ile
IV Regime
Elevated (60thโ80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AXNX nor ATRC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.